Oral Session 2-14A CAR T Therapy

[OS2-14A-5] Blastic transformation of vector-marked cells in X-CGD patient with retrovirus-mediated gene therapy

Toru Uchiyama¹, Toshinao Kawai², Kazuhiko Nakabayashi³, Yukiko Ando¹, Yumi Akiba¹, Tomoko Minegishi¹, Nobuyuki Watanabe¹, Akane Miura¹, Toru Yasuda¹, Motohiro Kato⁴, Koji Kato⁵, Toyoki Nishimura⁶, Hiroyuki Nunoi⁶, Masafumi Onodera¹ (1.Dept. Human Genetics, NCCHD, Tokyo, Japan, 2.Div. Immunol., NCCHD, Tokyo, Japan, 3.Dept. Maternal-Fetal Biol., NCCHD, Tokyo Japan, 4.Child. Cancer Center, NCCHD, Tokyo, Japan, 5.Dept. Med. Biosys. Sci., Kyushu Univ., Fukuoka, Japan, 6.Div. Pediatr., Miyazaki Univ., Miyazaki, Japan)